Compare FRO & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRO | GMED |
|---|---|---|
| Founded | 1985 | 2003 |
| Country | Cyprus | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 11.0B |
| IPO Year | 1995 | 2012 |
| Metric | FRO | GMED |
|---|---|---|
| Price | $55.91 | $76.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | $54.25 | ★ $100.92 |
| AVG Volume (30 Days) | ★ 3.9M | 1.5M |
| Earning Date | 11-30-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.98% | N/A |
| EPS Growth | N/A | ★ 422.67 |
| EPS | N/A | ★ 2.00 |
| Revenue | N/A | ★ $2,938,931,000.00 |
| Revenue This Year | $39.67 | $8.87 |
| Revenue Next Year | N/A | $6.04 |
| P/E Ratio | ★ $34.05 | $38.16 |
| Revenue Growth | N/A | ★ 16.65 |
| 52 Week Low | $20.47 | $58.32 |
| 52 Week High | $59.75 | $101.40 |
| Indicator | FRO | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 62.36 | 49.88 |
| Support Level | $34.50 | $73.91 |
| Resistance Level | N/A | $77.66 |
| Average True Range (ATR) | 1.72 | 1.64 |
| MACD | 0.44 | 0.39 |
| Stochastic Oscillator | 68.16 | 68.09 |
Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. It owns and operates modern fleets in the industry, consisting of VLCCs, Suezmax tankers, LR2, and Aframax tankers, which operate in the spot and time charter markets. The vessels normally trade between the larger refinery centers around the world, such as the Gulf of Mexico, the Middle East, Rotterdam, and Singapore. The company generates the majority of its revenue from voyage and time charters. It has only one reportable segment: tankers.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.